GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiVictriX Therapeutics PLC (LSE:BVX) » Definitions » Pretax Margin %

BiVictriX Therapeutics (LSE:BVX) Pretax Margin % : % (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BiVictriX Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. BiVictriX Therapeutics's Pre-Tax Income for the six months ended in Jun. 2024 was £-1.59 Mil. BiVictriX Therapeutics's Revenue for the six months ended in Jun. 2024 was £0.00 Mil. Therefore, BiVictriX Therapeutics's pretax margin for the quarter that ended in Jun. 2024 was %.

The historical rank and industry rank for BiVictriX Therapeutics's Pretax Margin % or its related term are showing as below:


LSE:BVX's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -134.73
* Ranked among companies with meaningful Pretax Margin % only.

BiVictriX Therapeutics Pretax Margin % Historical Data

The historical data trend for BiVictriX Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BiVictriX Therapeutics Pretax Margin % Chart

BiVictriX Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial - - - - -

BiVictriX Therapeutics Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BiVictriX Therapeutics's Pretax Margin %

For the Biotechnology subindustry, BiVictriX Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BiVictriX Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BiVictriX Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where BiVictriX Therapeutics's Pretax Margin % falls into.


;
;

BiVictriX Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

BiVictriX Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-3.003/0
= %

BiVictriX Therapeutics's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-1.593/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BiVictriX Therapeutics  (LSE:BVX) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


BiVictriX Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of BiVictriX Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BiVictriX Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
Alderley Edge, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG
BiVictriX Therapeutics PLC is a drug development company. It has developed its proprietary Bi-Cygni technology which utilizes Antibody Drug Conjugates for the treatment of various cancers including Acute Myeloid Leukaemia. The Group has one reportable segment, being the development of pharmaceutical products within the United Kingdom.

BiVictriX Therapeutics Headlines

No Headlines